首页 | 本学科首页   官方微博 | 高级检索  
   检索      


The biological activity of catfish pancreatic somatostatin
Authors:Hideki Oyama  Jeanne Martin  Karl Sussman  Gordon C Weir  Alan Permutt
Institution:1. Department of Medicine, Metabolism Division, Washington University School of Medicine, 660 S. Euclid, St. Louis, MO 63110, USA;2. Department of Pharmacology, Washington University School of Medicine, 660 S. Euclid, St. Louis, MO 63110, USA;3. Department of Medicine, University of Colorado Medical School, Medical Service, VA Medical Center, 1055 Clermont Street, Denver, CO 80220, USA;4. Department of Medicine, Medical College of Virginia, Health Sciences Center, Box 876, Richmond, VA 23298, U.S.A.
Abstract:Catfish pancreatic somatostatin, which contains eight additional amino acids on the amino terminus of a tetradecapeptide with considerable homology to tetradecapeptide somatostatin (SRIF), is a naturally occurring homology of the hypothalamic peptide. The purpose of these studies was to determibe the biological activity of this somatostatin homolog. Inhibition of 125I-labelled tyr1-SRIF binding to bovine pituitart plasma membranes by catfish pancreatic somatostatin was approximately 33% that of SRIF. Pancreatic somatostatin has full biological activity measured by inhibition of growth hormone release from isolated rat pituitary cells, but 0.01–0.1% the potency of SRIF. Pancreatic somatostatin at 100 ng/ml produced a 50–60% inhibition of insulin and glucagon secretion from perfused rat pancreas, while SRIF produced comparable inhibition at 10 ng/ml. This report demonstrates that a larger molecular form and natural homolog of SRIF, isolated from fish pancreas, has the same (but reduced) biological activities in rat assay systems as somatostatin originally isolated from sheep hypothalamus.
Keywords:receptor binding  growth hormone  insulin and glucagon secretion
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号